Funds holding Enliven Therapeutics Inc
ISIN US29337E1029 · United States
- Fund holders
- 174
- Of which ETFs
- 43 131 other funds
- Value held
- 518.4M $
- Share of capital
- 18.6 % of 73.3M shares on Jul 28, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 1,616,362 | 63.4M $ | 0.00 % | 2.21 % | as of Mar 31, 2026 ↗ |
| Select Health Care Portfolio Fidelity Select Portfolios | 1,280,000 | 38M $ | 0.61 % | 1.75 % | as of Feb 28, 2026 ↗ |
| Fidelity Small Cap Growth Fund Fidelity Securities Fund | 1,072,854 | 44.2M $ | 0.52 % | 1.46 % | as of Apr 30, 2026 ↗ |
| iShares Russell 2000 ETF iShares Trust | 966,241 | 37.9M $ | 0.05 % | 1.32 % | as of Mar 31, 2026 ↗ |
| Fidelity Stock Selector Small Cap Fund Fidelity Capital Trust | 653,091 | 26.9M $ | 0.39 % | 0.89 % | as of Apr 30, 2026 ↗ |
| Fidelity Advisor Health Care Fund Fidelity Advisor Series VII | 580,000 | 23.9M $ | 0.83 % | 0.79 % | as of Apr 30, 2026 ↗ |
| Fidelity Small Cap Growth K6 Fund Fidelity Securities Fund | 569,804 | 23.5M $ | 0.55 % | 0.78 % | as of Apr 30, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 497,384 | 19.5M $ | 0.02 % | 0.68 % | as of Mar 31, 2026 ↗ |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 389,406 | 16.1M $ | 0.05 % | 0.53 % | as of Apr 30, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 363,267 | 10.8M $ | 0.20 % | 0.50 % | as of Feb 28, 2026 ↗ |
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 328,862 | 13.6M $ | 0.71 % | 0.45 % | as of Apr 30, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 322,556 | 12.6M $ | 0.16 % | 0.44 % | as of Mar 31, 2026 ↗ |
| iShares Russell 2000 Growth ETF iShares Trust | 319,687 | 12.5M $ | 0.10 % | 0.44 % | as of Mar 31, 2026 ↗ |
| AB Small Cap Growth Portfolio AB CAP FUND, INC. | 317,187 | 13.1M $ | 0.45 % | 0.43 % | as of Apr 30, 2026 ↗ |
| Fidelity Series Small Cap Opportunities Fund Fidelity Securities Fund | 316,526 | 13.1M $ | 0.26 % | 0.43 % | as of Apr 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 235,002 | 7M $ | 0.02 % | 0.32 % | as of Feb 28, 2026 ↗ |
| VIP Health Care Portfolio Variable Insurance Products Fund IV | 218,000 | 8.5M $ | 0.85 % | 0.30 % | as of Mar 31, 2026 ↗ |
| Schwab U.S. Small-Cap ETF SCHWAB STRATEGIC TRUST | 215,061 | 6.4M $ | 0.03 % | 0.29 % | as of Feb 28, 2026 ↗ |
| VANGUARD RUSSELL 2000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 195,031 | 5.8M $ | 0.04 % | 0.27 % | as of Feb 28, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF SPDR SERIES TRUST | 192,297 | 7.5M $ | 2.45 % | 0.26 % | as of Mar 31, 2026 ↗ |
| U.S. SMALL CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 179,736 | 7.4M $ | 0.04 % | 0.25 % | as of Apr 30, 2026 ↗ |
| Dimensional U.S. Small Cap ETF Dimensional ETF Trust | 175,955 | 7.3M $ | 0.05 % | 0.24 % | as of Apr 30, 2026 ↗ |
| Fidelity Small Cap Value Fund Fidelity Securities Fund | 165,777 | 6.8M $ | 0.13 % | 0.23 % | as of Apr 30, 2026 ↗ |
| Fidelity Advisor Small Cap Fund Fidelity Advisor Series I | 135,700 | 4M $ | 0.18 % | 0.19 % | as of Feb 28, 2026 ↗ |
| iShares U.S. Pharmaceuticals ETF iShares Trust | 124,406 | 4.9M $ | 0.49 % | 0.17 % | as of Mar 31, 2026 ↗ |
| U.S. MICRO CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 101,773 | 4.2M $ | 0.06 % | 0.14 % | as of Apr 30, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 99,196 | 3.9M $ | 0.32 % | 0.14 % | as of Mar 31, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 98,572 | 2.9M $ | 0.01 % | 0.13 % | as of Feb 28, 2026 ↗ |
| SmallCap Growth Fund I Principal Funds, Inc | 92,383 | 3.8M $ | 0.16 % | 0.13 % | as of Apr 30, 2026 ↗ |
| Schwab Small-Cap Index Fund SCHWAB CAPITAL TRUST | 86,308 | 3.6M $ | 0.05 % | 0.12 % | as of Apr 30, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 84,905 | 2.5M $ | 0.00 % | 0.12 % | as of Feb 28, 2026 ↗ |
| Fidelity Small Cap Stock Fund Fidelity Concord Street Trust | 81,755 | 3.4M $ | 0.26 % | 0.11 % | as of Apr 30, 2026 ↗ |
| iShares Core S&P Total U.S. Stock Market ETF iShares Trust | 70,971 | 2.8M $ | 0.00 % | 0.10 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 65,420 | 1.9M $ | 0.00 % | 0.09 % | as of Feb 28, 2026 ↗ |
| Master Small Cap Index Series Quantitative Master Series LLC | 60,923 | 2.4M $ | 0.05 % | 0.08 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 53,863 | 2.1M $ | 0.02 % | 0.07 % | as of Mar 31, 2026 ↗ |
| iShares ESG Aware MSCI USA Small-Cap ETF iShares Trust | 53,210 | 1.6M $ | 0.07 % | 0.07 % | as of Feb 28, 2026 ↗ |
| Fidelity Fundamental Small-Mid Cap ETF Fidelity Covington Trust | 51,358 | 2.1M $ | 0.16 % | 0.07 % | as of Apr 30, 2026 ↗ |
| Avantis U.S. Small Cap Equity ETF American Century ETF Trust | 47,718 | 1.4M $ | 0.06 % | 0.07 % | as of Feb 28, 2026 ↗ |
| Nuveen Small Cap Blend Index Fund TIAA-CREF Funds | 46,120 | 1.9M $ | 0.05 % | 0.06 % | as of Apr 30, 2026 ↗ |
| Lord Abbett Micro-Cap Growth Fund LORD ABBETT SECURITIES TRUST | 45,526 | 1.9M $ | 0.92 % | 0.06 % | as of Apr 30, 2026 ↗ |
| EQ/2000 Managed Volatility Portfolio EQ Advisors Trust | 40,389 | 1.6M $ | 0.05 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 38,910 | 1.2M $ | 0.01 % | 0.05 % | as of Feb 28, 2026 ↗ |
| VANGUARD RUSSELL 2000 GROWTH INDEX FUND VANGUARD SCOTTSDALE FUNDS | 36,056 | 1.1M $ | 0.07 % | 0.05 % | as of Feb 28, 2026 ↗ |
| NICHOLAS PARTNERS SMALL CAP GROWTH FUND ADVISORS' INNER CIRCLE III | 35,883 | 1.4M $ | 0.94 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Nuveen ESG Small-Cap ETF NuShares ETF Trust | 34,350 | 1.4M $ | 0.11 % | 0.05 % | as of Apr 30, 2026 ↗ |
| U.S. CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 33,017 | 1.4M $ | 0.00 % | 0.05 % | as of Apr 30, 2026 ↗ |
| Invesco Dorsey Wright Healthcare Momentum ETF Invesco Exchange-Traded Fund Trust | 31,343 | 1.3M $ | 1.07 % | 0.04 % | as of Apr 30, 2026 ↗ |
| Schwab U.S. Broad Market ETF SCHWAB STRATEGIC TRUST | 30,342 | 900.9K $ | 0.00 % | 0.04 % | as of Feb 28, 2026 ↗ |
| Fidelity Small Cap Growth Index Fund Fidelity Salem Street Trust | 29,922 | 1.2M $ | 0.10 % | 0.04 % | as of Mar 31, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 29,088 | 1.1M $ | 0.00 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust | 28,939 | 1.2M $ | 0.00 % | 0.04 % | as of Apr 30, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 28,328 | 1.2M $ | 0.00 % | 0.04 % | as of Apr 30, 2026 ↗ |
| LVIP SSGA Small-Cap Index Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 25,400 | 995.7K $ | 0.05 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index ETF Fidelity Commonwealth Trust | 25,376 | 753.4K $ | 0.01 % | 0.03 % | as of Feb 28, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 24,399 | 956.4K $ | 0.00 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Fidelity ZERO Total Market Index Fund Fidelity Concord Street Trust | 23,228 | 957.7K $ | 0.00 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Nuveen Equity Index Fund TIAA-CREF Funds | 20,222 | 833.8K $ | 0.00 % | 0.03 % | as of Apr 30, 2026 ↗ |
| LVIP Franklin Templeton Multi-Factor SMID Cap Equity Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 20,151 | 789.9K $ | 0.09 % | 0.03 % | as of Mar 31, 2026 ↗ |
| EQ/Small Company Index Portfolio EQ Advisors Trust | 19,770 | 775K $ | 0.05 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Strategic Advisers Fidelity U.S. Total Stock Fund Fidelity Rutland Square Trust II | 19,595 | 581.8K $ | 0.00 % | 0.03 % | as of Feb 28, 2026 ↗ |
| Small Cap Index Fund Northern Funds | 18,594 | 728.9K $ | 0.05 % | 0.03 % | as of Mar 31, 2026 ↗ |
| AVIP AB Small Cap Portfolio AuguStar Variable Insurance Products Fund Inc | 17,281 | 677.4K $ | 0.25 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Fidelity Disruptive Medicine ETF Fidelity Covington Trust | 17,123 | 508.4K $ | 0.83 % | 0.02 % | as of Feb 28, 2026 ↗ |
| Global X Russell 2000 ETF GLOBAL X FUNDS | 17,045 | 702.8K $ | 0.05 % | 0.02 % | as of Apr 30, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 16,370 | 674.9K $ | 1.81 % | 0.02 % | as of Apr 30, 2026 ↗ |
| Fidelity ZERO Extended Market Index Fund Fidelity Concord Street Trust | 15,588 | 642.7K $ | 0.03 % | 0.02 % | as of Apr 30, 2026 ↗ |
| Small Cap Index Fund VALIC Co I | 15,504 | 460.3K $ | 0.04 % | 0.02 % | as of Feb 28, 2026 ↗ |
| Optimize Strategy Index ETF Advisor Managed Portfolios | 15,055 | 590.2K $ | 0.28 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Fidelity MSCI Health Care Index ETF FIDELITY COVINGTON TRUST | 14,804 | 610.4K $ | 0.02 % | 0.02 % | as of Apr 30, 2026 ↗ |
| Dimensional U.S. Equity Market ETF Dimensional ETF Trust | 14,379 | 592.8K $ | 0.00 % | 0.02 % | as of Apr 30, 2026 ↗ |
| STATE STREET SMALL/MID CAP EQUITY INDEX PORTFOLIO STATE STREET INSTITUTIONAL INVESTMENT TRUST | 13,668 | 535.8K $ | 0.02 % | 0.02 % | as of Mar 31, 2026 ↗ |
| EQ/AB Small Cap Growth Portfolio EQ Advisors Trust | 13,450 | 527.2K $ | 0.03 % | 0.02 % | as of Mar 31, 2026 ↗ |
| MetLife Russell 2000 Index Portfolio Brighthouse Funds Trust II | 12,502 | 490.1K $ | 0.05 % | 0.02 % | as of Mar 31, 2026 ↗ |
| ATM Small Cap Managed Volatility Portfolio EQ Advisors Trust | 12,019 | 471.1K $ | 0.05 % | 0.02 % | as of Mar 31, 2026 ↗ |
| iShares Russell 3000 ETF iShares Trust | 11,971 | 469.3K $ | 0.00 % | 0.02 % | as of Mar 31, 2026 ↗ |
| AST PGIM Aggressive Multi-Asset Portfolio Advanced Series Trust | 11,500 | 450.8K $ | 0.00 % | 0.02 % | as of Mar 31, 2026 ↗ |
| BlackRock Advantage Small Cap Growth Fund BlackRock Funds | 10,599 | 415.5K $ | 0.06 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Small-Cap Index Portfolio PACIFIC SELECT FUND | 10,363 | 406.2K $ | 0.05 % | 0.01 % | as of Mar 31, 2026 ↗ |
| JNL/DFA U.S. Small Cap Fund JNL Series Trust | 8,518 | 333.9K $ | 0.05 % | 0.01 % | as of Mar 31, 2026 ↗ |
| NVIT Small Cap Index Fund Nationwide Variable Insurance Trust | 7,859 | 308.1K $ | 0.05 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Dimensional US Core Equity Market ETF Dimensional ETF Trust | 7,755 | 319.7K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Bridge Builder Small/Mid Cap Growth Fund Bridge Builder Trust | 7,449 | 292K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Small Cap Index Trust John Hancock Variable Insurance Trust | 7,164 | 280.8K $ | 0.05 % | 0.01 % | as of Mar 31, 2026 ↗ |
| iShares Morningstar Small-Cap Value ETF iShares Trust | 7,138 | 294.3K $ | 0.05 % | 0.01 % | as of Apr 30, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 7,081 | 277.6K $ | 0.16 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Fidelity Flex Small Cap Index Fund Fidelity Salem Street Trust | 6,714 | 276.8K $ | 0.07 % | 0.01 % | as of Apr 30, 2026 ↗ |
| AB Small Cap Growth Portfolio AB VARIABLE PRODUCTS SERIES FUND, INC. | 6,234 | 244.4K $ | 0.51 % | 0.01 % | as of Mar 31, 2026 ↗ |
| U.S. Small Cap Equity Fund RUSSELL INVESTMENT CO | 6,157 | 253.9K $ | 0.03 % | 0.01 % | as of Apr 30, 2026 ↗ |
| PROFUND VP PHARMACEUTICALS ProFunds | 6,101 | 239.2K $ | 2.35 % | 0.01 % | as of Mar 31, 2026 ↗ |
| iShares Russell Small/Mid-Cap Index Fund BlackRock Funds | 5,867 | 241.9K $ | 0.02 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Small Cap Core Fund Northern Funds | 5,800 | 227.4K $ | 0.07 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Direxion Daily Pharmaceutical & Medical Bull 3X Shares Direxion Shares ETF Trust | 5,620 | 231.7K $ | 1.80 % | 0.01 % | as of Apr 30, 2026 ↗ |
| DWS Small Cap Index VIP DEUTSCHE DWS INVESTMENTS VIT FUNDS | 5,568 | 218.3K $ | 0.05 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Invesco RAFI US 1500 Small-Mid ETF Invesco Exchange-Traded Fund Trust | 5,485 | 226.1K $ | 0.01 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Diversified Equity Master Portfolio Master Investment Portfolio | 5,296 | 207.6K $ | 0.01 % | 0.01 % | as of Mar 31, 2026 ↗ |
| EQ/Morgan Stanley Small Cap Growth Portfolio EQ Advisors Trust | 5,265 | 206.4K $ | 0.05 % | 0.01 % | as of Mar 31, 2026 ↗ |
| SIIT EXTENDED MARKET INDEX FUND SEI INSTITUTIONAL INVESTMENTS TRUST | 5,200 | 154.4K $ | 0.01 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 4,993 | 205.9K $ | 0.03 % | 0.01 % | as of Apr 30, 2026 ↗ |
| NYLI WMC Small Companies Fund NEW YORK LIFE INVESTMENTS FUNDS TRUST | 4,917 | 202.7K $ | 0.06 % | 0.01 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Vitality Portfolio MORGAN STANLEY INSTITUTIONAL FUND INC | 3.90 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF SPDR SERIES TRUST | 2.45 % | as of Mar 31, 2026 ↗ |
| PROFUND VP PHARMACEUTICALS ProFunds | 2.35 % | as of Mar 31, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 1.81 % | as of Apr 30, 2026 ↗ |
| Direxion Daily Pharmaceutical & Medical Bull 3X Shares Direxion Shares ETF Trust | 1.80 % | as of Apr 30, 2026 ↗ |
| PHARMACEUTICALS ULTRASECTOR PROFUND ProFunds | 1.77 % | as of Apr 30, 2026 ↗ |
| Invesco Dorsey Wright Healthcare Momentum ETF Invesco Exchange-Traded Fund Trust | 1.07 % | as of Apr 30, 2026 ↗ |
| NICHOLAS PARTNERS SMALL CAP GROWTH FUND ADVISORS' INNER CIRCLE III | 0.94 % | as of Mar 31, 2026 ↗ |
| Lord Abbett Micro-Cap Growth Fund LORD ABBETT SECURITIES TRUST | 0.92 % | as of Apr 30, 2026 ↗ |
| VIP Health Care Portfolio Variable Insurance Products Fund IV | 0.85 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 174 | +19 | 13,658,962 | -7.4 % |
| 2026Q1 | 155 | +4 | 14,744,562 | +3.1 % |
| 2025Q4 | 151 | +7 | 14,296,096 | +12.5 % |
| 2025Q3 | 144 | -9 | 12,711,510 | +23.2 % |
| 2025Q2 | 153 | +7 | 10,318,195 | +0.4 % |
| 2025Q1 | 146 | +2 | 10,273,848 | +5.0 % |
| 2024Q4 | 144 | +16 | 9,782,919 | +13.6 % |
| 2024Q3 | 128 | +19 | 8,614,500 | +5.3 % |
| 2024Q2 | 109 | +6 | 8,179,416 | +10.6 % |
| 2024Q1 | 103 | +1 | 7,396,819 | +14.0 % |
| 2023Q4 | 102 | 6,489,084 |
Institutional managers
168 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| ORBIMED ADVISORS LLC | 7,959,538 | 312M $ | as of Mar 31, 2026 |
| FMR LLC | 6,829,246 | 267.7M $ | as of Mar 31, 2026 |
| Polar Capital Holdings Plc | 5,065,933 | 198.6M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 3,684,707 | 144.4M $ | as of Mar 31, 2026 |
| Commodore Capital LP | 3,275,000 | 128.4M $ | as of Mar 31, 2026 |
| Vestal Point Capital, LP | 3,250,000 | 127.4M $ | as of Mar 31, 2026 |
| Bellevue Group AG | 2,320,867 | 91M $ | as of Mar 31, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,168,162 | 85M $ | as of Mar 31, 2026 |
| Fairmount Funds Management LLC | 1,855,644 | 72.7M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 1,743,915 | 68.4M $ | as of Mar 31, 2026 |
| Venrock Adviser, LLC | 1,726,331 | 67.7M $ | as of Mar 31, 2026 |
| NOVO HOLDINGS A/S | 1,280,000 | 50.2M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 1,091,106 | 42.8M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,066,420 | 41.8M $ | as of Mar 31, 2026 |
| Pictet Asset Management Holding SA | 929,544 | 36.4M $ | as of Mar 31, 2026 |
| BAKER BROS. ADVISORS LP | 905,191 | 35.5M $ | as of Mar 31, 2026 |
| Rock Springs Capital Management LP | 826,500 | 32.4M $ | as of Mar 31, 2026 |
| ALLIANCEBERNSTEIN L.P. | 771,885 | 11.9M $ | as of Mar 31, 2026 |
| Siren, L.L.C. | 746,226 | 29.3M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 681,715 | 26.7M $ | as of Mar 31, 2026 |
| First Turn Management, LLC | 623,839 | 24.5M $ | as of Mar 31, 2026 |
| Candriam S.C.A. | 594,079 | 23.3M $ | as of Mar 31, 2026 |
| Jones Hill Capital LP | 593,040 | 23.2M $ | as of Mar 31, 2026 |
| Affinity Asset Advisors, LLC | 586,904 | 23M $ | as of Mar 31, 2026 |
| Logos Global Management LP | 540,000 | 21.2M $ | as of Mar 31, 2026 |
Declared shareholders of Enliven Therapeutics Inc
There are 6 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| ORBIMED ADVISORS LLC and 3 others | 9.50 % | 6,774,507 | as of Jun 22, 2026 · SCHEDULE 13D |
| Polar Capital Holdings Plc and 2 others | 8.46 % | 5,056,807 | as of Mar 31, 2026 · SCHEDULE 13G |
| Commodore Capital LP and 3 others | 7.70 % | 4,800,940 | as of Mar 31, 2026 · SCHEDULE 13G |
| Vestal Point Capital, LP and 1 other | 5.40 % | 3,250,000 | as of Mar 31, 2026 · SCHEDULE 13G |
| Fairmount Funds Management LLC and 3 others | 3.10 % | 1,855,644 | as of Mar 31, 2026 · SCHEDULE 13G |
| Venrock Healthcare Capital Partners III, L.P. and 6 others | 2.80 % | 1,726,331 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding Enliven Therapeutics Inc". https://titelia.com/en/stocks/enliven-therapeutics-inc-US29337E1029